Clarity Pharma (CU6) is held by 6 ASX ETFs. Over the last 3 months it fell 24.0%: on $10,000, −$2396. We explain 2 big moves in that time.
About CU6
- SectorHealth Care
- IndustryPharmaceuticals, Biotechnology & Life Sciences
- Size$716.3m
- Held by6 ETFs
- Big moves2 in 3M
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- −5.9%peak −6.4%9 Oct 2026· Operational
Clarity Pharmaceuticals likely fell on profit-taking or disappointment after news of achieving its SECuRE cohort recruitment target failed to sustain the prior rally, with no new positive catalyst to drive further gains.
- +7.1%peak +15.5%5 Aug 2026· Sector Flow
CU6 rose sharply alongside a broader rally in Australian healthcare stocks, lifting the stock well above its normal daily range.
Held by 6 ETFs
Of every $10,000 in each fund, how much is in CU6 today.
- SSOSTATE STREET SPDR S&P/ASX SMALL ORDINARIES ETF$240.24%
- ISOiShares S&P/ASX Small Ordinaries ETF$240.24%
- VSOVanguard MSCI Australian Small Companies Index ETF$110.11%
- VETHVanguard Ethically Conscious Australian Shares ETF$3.360.03%
- VASVanguard Australian Shares Index ETF$2.740.03%
- A300Global X Australia 300 ETF$2.410.02%
Why did CU6 rise 7.1% on 5 Aug 2026?
Clarity Pharma
CU6 rose sharply alongside a broader rally in Australian healthcare stocks, lifting the stock well above its normal daily range.
The only identifiable signal is a 1.78% gain in the ASX Health sector index (^AXHJ), which directionally matches the move and is above its normal threshold, suggesting sector tailwinds played a role. However, the sector move alone (1.78%) is far too modest to fully explain a 9.52% surge at 3.4x normal ATR, meaning a company-specific catalyst is likely also at play. With no announcements, no news, and no peer signals found, the residual cause remains unidentified, keeping confidence in the circumstantial range.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice. It does not consider your objectives, finances or needs. Past performance is not a guide to future performance.
Evidence
Sector / macro signals
What it did to the 6 ETFs holding CU6
On $10,000 in each fund, at the weight it holds today